The first participant has been enrolled in a Phase 2 clinical trial testing AC-203 for the treatment of inherited epidermolysis…
Articles by Janet Stewart, MSc
U.S. residents with some types of inherited epidermolysis bullosa (EB) can now participate in Amryt Pharma‘s Phase 3 trial…
The U.S. Food and Drug Administration has cleared Krystal Biotech‘s investigational new drug application for KB103, a topical…
A bone-anchored hearing aid was implanted in a patient with epidermolysis bullosa (EB) who had mixed hearing loss, according…
A Phase 2/3 clinical trial testing diacerein in the form of a cream applied to the skin showed that it…
Researchers found two mutations in a gene that carries the instructions for the protein plectin in a patient with epidermolysis…
Orphan Drug Designation was recently granted to ProQR Therapeutics’ investigational therapy QR-313 for the treatment of dystrophic epidermolysis…
Low bone mineral density, a measure of bone health, was associated with low vitamin D levels and more severe disease…
Cannabinoid therapy developer InMed and French tissue engineering company ATERA have teamed up to develop 3-D human skin…
The European Medicines Agency (EMA) recently granted Tarix Orphan’s lead investigational product TXA127 orphan drug status for the…